|
Public Health - VOSI Research
Report RR13-V50.3A
"STANDARD TO DELAY VACCINATING NEWBORNS"
References:
-
"IgE in Umbilical Cord Blood", Dr Robert Hariri, MD, Lifebank
CEO, Cedar Knolls, NJ
-
"A B C’s of Interpretive Laboratory Data", Bakerman,
Seymour, MD, Ph.D.
-
"VOSI V50.3A, Standard to Delay Vaccinating Newborns", par.
2.1
-
"Neonatal Umbilical Cord IgE Tests:
Rationale for Their Use in Screening Infants for Impaired
Immunity and Increased Vulnerability to Childhood
Vaccines", Buttram, Harold E., MD, January 5, 2003
Purpose:
To verify 2.0 U/ml maximum IgE for newborn’s umbilical cord blood (ref. 2).
Test Procedure:
A total of 845 male and 778 female cord blood samples
were tested for IgE per Ref. 1 test procedures.
Test Results:
|
Original Data Provided by Dr. Hariri,
Lifebank CEO |
| Table 1. |
 |
|
Data Provided by Lifebank - February 16,
2003 |
| Table 2. |
 |
Table 1 is the summary of the IgE tests by Dr.
Robert Hariri, Lifebank CEO.
Individual test results were not supplied for the total 1623
tests.
Table 2 is the summary of the 1183 individual
tests supplied by Lifebank.
VOSI paid for a minimum of 1600 individual tests, and there are
440 individual test results missing from Table 2.
Because of these differences Table 1 probably
has the correct total number of tests but the 39 greater than 2
U/ml and the associated % results are probably incorrect based
on the actual 60 greater than 2.0 U/ml totals seen in Table 2.
Conclusions
-
This study verifies the accuracy of 2.0 Units/ml as the maximum
permissible IgE in the Umbilical cord blood of newborns specified in Ref.
2.
-
Approximately 2.5% of newborns should not be vaccinated until their
immune system meets the minimum IgE age dependent values specified in VOSI
V50.3A.
-
The practice of immunizing newborns with Hepatitis B should be
discontinued based on the immune system not being fully developed until age 2 (Ref. 4.2 V50.3A)
and screening their mothers for Hepatitis B.
-
Ref. 3 should be accepted and utilized by
the Advisory Committee on Immunization Practices (ACIP)
The $16,000 cost of this study was funded by private, non-governmental
donations. Major donors (in excess of $2000) were the Autism Research Institute, the Hekemian
Family Fund of the Armenian Missionary Association of America and Steve and
Brian Meserlian. VOSI would like to thank all donors who made this study
possible.
|
